Autopsy report · NCT06137963

Digital Diabetes Prevention Program Study

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“This study is no longer feasible due to the increasing number of diabetic patients who are prescribed Ozempic and other GLP-1 agonists.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Na
Sponsor: Hospital for Special Surgery, New York
Sponsor type: University, hospital or other
Conditions: PreDiabetes
Interventions: Transform10 Diabetes Prevention Program
Participants: 0
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.